Wolfson Institute for Biomedical Research
The Wolfson Institute for Biomedical Research was established at UCL in 1995 for the pursuit of excellence in translational biomedical research. Now, with its primary focus on fundamental and translational neuroscience, the WIBR is a key hub within the rich environment of the UCL neuroscience community.
The WIBR is currently home to 14 Principal Investigators, including established senior academics as well as early-career scientists. Collectively we hold more than £25m in grants from The European Research Council, MRC, BBSRC, Wellcome and other biomedical research charities.
Researchers within the WIBR organise and contribute to several distinguised undergraduate modules within the School of Life and Medical Sciences. The Institute has around 20 current PhD students, and runs a highly rated one-year MSc degree course in Drug Design.
Contact details for WIBR staff
Find out more about WIBR history
Iseppon, F., Luiz, A. P., Linley, J. E., & Wood, J. N. (2023). Pregabalin silences oxaliplatin-activated sensory neurons to relieve cold allodynia. eNeuro, ENEURO.0395-ENEU22.2022. doi:10.1523/ENEURO.0395-22.2022
Qin, Q., Wang, M., Li, H., Xu, Z. D., & Tang, Y. (2023). Editorial: The role of microglia in the pathogenesis of neurodegenerative diseases. Frontiers in Aging Neuroscience, 14, 1105896. doi:10.3389/fnagi.2022.1105896
Zhu, W., Li, W., Jiang, J., Wang, D., Mao, X., Zhang, J., . . . Li, N. (2023). Chronic salmon calcitonin exerts an antidepressant effect via modulating the p38 MAPK signaling pathway. Frontiers in Molecular Neuroscience, 16, 1071327. doi:10.3389/fnmol.2023.1071327